Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows ​| Fortune | FORTUNE

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults.. SIGRID GOMBERT/SCIENCE PHOTO LIBRARY/GETTY IMAGES

Read original article on Fortune | FORTUNE Read More